Ticker Details
Sight Sciences, Inc. Common Stock
IPO Date:	July 12, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$189.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 3.55%
Avg Daily Range (30 D):	$0.14 | 3.44%
Avg Daily Range (90 D):	$0.17 | 2.83%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.29M
Avg Daily Volume (90 D):	.23M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	129
Avg Institutional Trade:	$2.27M
Avg Institutional Trade (30 D):	$1.06M
Avg Institutional Trade (90 D):	$1.18M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.3M
Avg Closing Trade (30 D):	$1.06M
Avg Closing Trade (90 D):	$1.28M
Avg Closing Volume:	259.54K

News

Sep 9, 2025 @ 3:39 PM UnitedHealthcare Adds Sight Sciences OMNI System T... Source: Vandana Singh

Jul 30, 2025 @ 11:00 AM Sight Sciences Announces the Results of a Cost-Uti... Source: Nathan Lighthizer Et Al.

Jul 29, 2025 @ 11:00 AM Sight Sciences Announces the Publication of the 24... Source: Sight Sciences, Inc.

Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica

Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.74	$-.08	$-.74
Diluted EPS	$-.74	$-.08	$-.74
Revenue	$77.36M	$20.39M	$77.36M
Gross Profit	$66.67M	$17.79M	$66.67M
Net Income / Loss	$-38.43M	$-4.16M	$-38.43M
Operating Income / Loss	$-37.1M	$-3.67M	$-37.1M
Cost of Revenue	$10.7M	$2.6M	$10.7M
Net Cash Flow	$-28.13M	$-.41M	$-28.13M
PE Ratio